Detalhe da pesquisa
1.
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.
Br J Cancer
; 126(3): 449-455, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34811502
2.
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study.
Oncologist
; 27(1): e29-e36, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305093
3.
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma.
Oncologist
; 26(12): 1079-1084, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355463
4.
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis.
Oncologist
; 26(4): 302-309, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336844
5.
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.
Int J Cancer
; 147(8): 2303-2315, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270478
6.
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.
Br J Cancer
; 123(3): 403-409, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424148
7.
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.
Oncologist
; 25(3): e460-e468, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162808
8.
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden.
Oncologist
; 25(9): 803-809, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32369650
9.
Clinical Behavior and Treatment Response of Epstein-Barr Virus-Positive Metastatic Gastric Cancer: Implications for the Development of Future Trials.
Oncologist
; 25(9): 780-786, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32272500
10.
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs).
Int J Cancer
; 144(7): 1704-1712, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520016
11.
Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study.
Oncologist
; 24(7): e536-e541, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518617
12.
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?
Pharmacogenomics J
; 19(5): 465-472, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30713338
13.
Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.
Oncology
; 97(1): 38-43, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048579
14.
Immunotherapy-based combinations: an update.
Curr Opin Oncol
; 30(5): 345-351, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29994900
15.
Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features.
Oncology
; 94(1): 1-6, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28869928
16.
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.
Oncology
; 95(6): 344-352, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30130791
17.
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.
Br J Cancer
; 117(3): 347-352, 2017 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28654634
18.
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.
Oncology
; 93(5): 279-286, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28881354
19.
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
Gynecol Oncol
; 144(1): 90-95, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27817933
20.
Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis.
Gynecol Oncol
; 143(2): 443-447, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27481579